Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × capmatinib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 122 Cisplatin 64 Specimen Handling 62 Carboplatin 62 Biopsy 53 Cyclophosphamide 52 Nivolumab 51 Magnetic Resonance Spectroscopy 50 Paclitaxel 45 Gemcitabine 37 Radiotherapy 36 Doxorubicin 35 durvalumab 32 Dexamethasone 29 olaparib 28 Rituximab 28 Lenalidomide 27 Ipilimumab 27 fludarabine 26 Radiation 25 Pemetrexed 25 atezolizumab 23 Etoposide 23 Docetaxel 23 Vincristine 22 Prednisone 22 Bevacizumab 22 Taxes 20 Fluorouracil 20 Radiotherapy, Intensity-Modulated 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04677595 2026-03-31

GeoMETry-C

Novartis

Phase 2 Completed

36 enrolled 26 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡